1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in Japan, June 2018 (p5)

Biotechnology Analysis & Statistics in Japan, June 2018 (p5)

121-150 of about 300 reports

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business Strategies--Supplier Shares and Market Segment Forecasts----Technological Breakthroughs, Emerging Tests, Competitive Intelligence

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business Strategies--Supplier Shares and Market Segment Forecasts----Technological Breakthroughs, Emerging Tests, Competitive Intelligence

  • $ 15900
  • Industry report
  • June 2018

This new seven-country study contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : Japan, France, Germany, Italy, Spain, United Kingdom, United States
Tumor Markers: Unlocking Mystery of Cancer--US, Europe, Japan--Suppliers Shares and Market Segment Forecasts by Tumor Marker and Country, Competitive Intelligence, Technological Breakthroughs, Emerging Tests

Tumor Markers: Unlocking Mystery of Cancer--US, Europe, Japan--Suppliers Shares and Market Segment Forecasts by Tumor Marker and Country, Competitive Intelligence, Technological Breakthroughs, Emerging Tests

  • $ 15900
  • Industry report
  • June 2018

This new seven-country study contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : Japan, United States, Europe, France, Germany, Italy, Spain, United Kingdom
Inclisiran

Inclisiran

  • $ 10000
  • Industry report
  • June 2018

OverviewInclisiran (The Medicines Company/Alnylam Pharmaceuticals) is a systemically delivered siRNA therapeutic targeting mRNA for PCSK. Inclisiran targets both intracellular and extracellular PCSK9, ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : United States, Japan, European Union
2018 Global Adenovirus Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Adenovirus Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 2800
  • Industry report
  • June 2018

The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology ...

  • Industries : Medical Biotechnology, Diagnostics, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Europe, Japan, World, France, Germany, Italy, Spain, United Kingdom
2018 Japan Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Japan Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 5500
  • Industry report
  • June 2018

This new 1126-page report contains 56 tables, and presents a comprehensive analysis of the Japanese molecular diagnostics market, including: Major issues pertaining to the Japanese molecular diagnostics ...

  • Industries : Genomics Proteomics and Enabling Technology, Biotechnology
  • Countries : Japan
2018 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1500
  • Industry report
  • June 2018

About This ReportThis new 282-page report .com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, ...

  • Industries : Medical Biotechnology, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Japan
2018 Japan Enteric Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Japan Enteric Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1700
  • Industry report
  • June 2018

About This ReportThis new 322-page report .com presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Medical Biotechnology
  • Countries : Japan
2018 Global Molecular Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Molecular Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 15900
  • Industry report
  • June 2018

This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : Japan, United States, World, Europe, France, Germany, Italy, Spain, United Kingdom
2018 Japan Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

2018 Japan Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

  • $ 5700
  • Industry report
  • June 2018

SummaryThis comprehensive report contains 250 pages, 32 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Japanese ...

  • Industries : Medical Biotechnology
  • Countries : Japan
2018 Global Hematology and Flow Cytometry Market: US, Europe, Japan--Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers

2018 Global Hematology and Flow Cytometry Market: US, Europe, Japan--Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 15900
  • Industry report
  • June 2018

SummaryThis comprehensive seven-country report contains 700 pages, 250 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Healthcare, Health Services
  • Countries : World, United States, Japan, Europe, France, Germany, Italy, Spain, United Kingdom
2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 21100
  • Industry report
  • June 2018

The new report is a seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U.S., five ...

  • Industries : Health Services, Medical Biotechnology
  • Countries : World, Japan, United States, Europe, France, Germany, Italy, Spain, United Kingdom
2018 Japan Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Japan Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 4900
  • Industry report
  • June 2018

The new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Japanese cancer diagnostics ...

  • Industries : Medical Biotechnology, Diagnostics, Biopharmaceutical, Biopharmaceutical, Diagnostic Imaging
  • Countries : Japan
2018 Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

2018 Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

  • $ 3500
  • Industry report
  • June 2018

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Europe, France, Germany, Italy, Spain, United Kingdom, Japan
Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018

  • $ 2000
  • Company report
  • June 2018

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal ...

  • Industries : Pathology, Chronic Disease, Pharmaceutical, Healthcare, Medical Biotechnology
  • Countries : United States, Japan, World, East Asia
Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026

Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026

  • $ 3495
  • Industry report
  • June 2018

Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026SummaryAxial Spondyloarthritis (AxSpA) is a chronic, immune-mediated inflammatory disease of the axial skeleton (sacroiliac joints and spine). ...

  • Industries : Medical Biotechnology, Drug Development, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, World, Japan
2018 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Emerging Opportunities

2018 Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • June 2018

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Europe, France, Germany, Italy, Spain, United Kingdom, Japan
Biotechnology in Japan

Biotechnology in Japan

  • $ 350
  • Industry report
  • June 2018

Biotechnology in JapanSummaryBiotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The ...

  • Industries : Biotechnology, Pharmaceutical
  • Countries : Japan, East Asia
Cell Isolation Market by Product , by Cell Type , by Technique , by Application , by End User , by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

Cell Isolation Market by Product , by Cell Type , by Technique , by Application , by End User , by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

  • $ 4900
  • Industry report
  • June 2018

Global cell isolation market size is expected to reach $12.6 billion by 2023,The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical
  • Countries : World, APAC, North America, Europe, Japan, China, India, United States, Canada, Germany, United Kingdom, Brazil, Mexico, South Africa, East Asia
Pollen Allergy Global Clinical Trials Review, H1, 2018

Pollen Allergy Global Clinical Trials Review, H1, 2018

  • $ 2500
  • Industry report
  • May 2018

Pollen Allergy Global Clinical Trials Review, H1, 2018SummaryGlobalData’s clinical trial report, “Pollen Allergy Global Clinical Trials Review, H1, 2018" provides an overview of Pollen Allergy clinical ...

  • Industries : Pharmaceutical, Chronic Disease, Medical Biotechnology, Drug Development, Pathology, Therapy
  • Countries : World, Japan
CellSeed Inc (7776) - Product Pipeline Analysis, 2018 Update

CellSeed Inc (7776) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • May 2018

SummaryCellSeed Inc (CellSeed) is a biotechnology company that develops and offers solutions for tissue-engineering through novel cell harvest methods.The company’s products include epithelial cell sheet ...

  • Industries : Drug Development
  • Countries : Japan
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2018

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2018

  • $ 3500
  • Company report
  • May 2018

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2018SummaryWilms Tumor Protein (WT33 or WT1) - Wilms tumor protein is a protein that is encoded by the WT1 gene. It plays an important role in cellula ...

  • Industries : Cancer, Pathology, Therapy, Medical Biotechnology, Pharmaceutical
  • Countries : United States, Japan
Enbrel

Enbrel

  • $ 10000
  • Industry report
  • May 2018

Drug OverviewEnbrel (etanercept; Amgen/Pfizer/Takeda) is a dimeric fusion protein consisting of the extracellular ligand binding portion of tumor necrosis factor (TNF) receptor linked to the Fc portion ...

  • Industries : Medical Biotechnology, Pathology, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Global Collagen and HA-Based Biomaterials Industry

Global Collagen and HA-Based Biomaterials Industry

  • $ 5800
  • Industry report
  • May 2018

This report analyzes the worldwide markets for Collagen and HA-Based Biomaterials in US$ Thousand by the following Application Areas: Collagen-based Biomaterials (Urinary Incontinence, Corneal Shields, ...

  • Industries : Industrial Biotechnology, Biomaterial
  • Countries : APAC, World, Europe, United States, Japan, Canada
Critical Limb Ischemia (CLI) Drug Development- Pipeline Analysis Report

Critical Limb Ischemia (CLI) Drug Development- Pipeline Analysis Report

  • $ 999
  • Industry report
  • April 2018

Critical Limb Ischemia (CLI) is a catastrophic condition representing the most advanced phase of peripheral arterial disease. Patients witness strong blocking of the arteries, resulting in decreased blood ...

  • Industries : Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Therapy
  • Countries : Japan
Osteoporosis: Global Drug Forecast and Market Analysis to 2027

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • Industry report
  • April 2018

Osteoporosis: Global Drug Forecast and Market Analysis to 2027SummaryGlobal Osteoporosis pharmaceutical market in 2017 was $7.4B, including both branded and generic products. The branded market accounted ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : World, United States, Japan
Cedar Pollen Allergy - Pipeline Review, H1 2018

Cedar Pollen Allergy - Pipeline Review, H1 2018

  • $ 2000
  • Company report
  • March 2018

Cedar Pollen Allergy - Pipeline Review, H1 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cedar Pollen Allergy - Pipeline Review, H1 2018, provides an ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology
  • Countries : Japan, World
Global Lactic Acid Industry

Global Lactic Acid Industry

  • $ 5600
  • Industry report
  • March 2018

This report analyzes the worldwide markets for Lactic Acid in Metric Tons by the following End Use Segments: Food and Beverages, Biodegradable Polymers, Pharmaceutical, Personal Care, and Others.The report ...

  • Industries : Industrial Biotechnology, Food, Plastic, Biomaterial
  • Countries : APAC, Japan, World, Europe, United States, Canada, Latin America
Drug Analysis: Fasenra

Drug Analysis: Fasenra

  • $ 10000
  • Industry report
  • February 2018

Drug OverviewFasenra (benralizumab; AstraZeneca/Kyowa Hakko Kirin) is a humanized monoclonal antibody which binds to the alpha chain of the interleukin (IL)-5 receptor on eosinophils and therefore depletes ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : United States, Japan, European Union
Drug Overview: Xolair

Drug Overview: Xolair

  • $ 10000
  • Industry report
  • February 2018

Drug OverviewXolair (omalizumab; Roche/Novartis) is a recombinant humanized monoclonal antibody for the treatment of moderate to severe persistent allergic asthma. The drug inhibits the binding of immunoglobulin ...

  • Industries : Medical Biotechnology, Therapy, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, European Union
Drug Analysis: Dupixent

Drug Analysis: Dupixent

  • $ 10000
  • Industry report
  • February 2018

Drug OverviewDupixent (dupilumab; Regeneron/Sanofi) is an injectable monoclonal antibody directed against the interleukin (IL)-4 receptor alpha subunit, which blocks signaling from both IL-4 and IL-13. ...

  • Industries : Medical Biotechnology
  • Countries : United States, Japan, European Union

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on